Novavax's Vaccine Victory Comes With Caveats Plus Virtual Therapy: Is It Worth It?

By Zeus! Another Vaccine Enters the Arena!

Greetings mortals! Wonder Woman here reporting live from… well everywhere because frankly threats to humanity don't adhere to geographic boundaries. The news is that Novavax's COVID 19 vaccine has finally been granted FDA approval. Huzzah! Though if I'm being honest even Aphrodite's beauty can't distract from the fact that this approval comes with more restrictions than a Themysciran bachelorette party. It's limited to the over 65s and those with underlying conditions. Apparently Uncle Sam is feeling a bit…cautious. Someone needs to remind them that 'courage is not the absence of fear but rather the assessment that something else is more important than fear.' Perhaps a Lasso of Truth flavored reminder is in order!

Kennedy's Skepticism: Even Heroes Have Their Doubts!

These new restrictions seem to reflect the skepticism of Health and Human Services Secretary Robert F. Kennedy Jr. and other leaders he has appointed across federal health agencies have about vaccines. I certainly cannot agree with skepticism against the vaccines it might be a test of our strength our courage and our resolve. As my mother always says 'If you are going to do something then do it with all your heart!'

Novavax vs. The mRNA Titans: A David and Goliath Reboot?

This Novavax vaccine is being touted as an alternative to the mRNA shots from Pfizer and Moderna. These companies’ COVID jabs are already fully approved for use in anyone 12 and older and authorized for use in children as young as 6 months. But all three companies must secure additional approval to update the strain targeted by their respective shots ahead of the fall and winter vaccination season. Is this going to be another clash of titans? Well let's just say that even Ares would find this a bit… bureaucratic. But seriously it’s crucial we have options! Choice after all is the cornerstone of freedom and sometimes a good old fashioned dust up between companies is what we need to spur innovation.

Heart of the Matter: Myocarditis Concerns!

Now here's where things get a bit thorny. The FDA wants Novavax to conduct studies on the potential link between its vaccine and heart conditions like myocarditis. They are requiring the company to complete several studies on whether its vaccine is also associated with several heart conditions such as myocarditis or inflammation of the heart muscle. (Cases of myocarditis among people who have received Covid shots are rare and mainly reported in teenage boys). So it's not all Amazonian victory dances and celebratory ambrosia. Some analysts are calling the approval a win but I'm keeping a wary eye on those 'post marketing' requirements. I suppose even superheroes have to appreciate the value of due diligence. "It is our sacred duty to defend the world." So yeah let's make sure this vaccine is as safe as Hephaestus's finest shield.

Sanofi to the Rescue: A Powerhouse Partnership

The good news is that Novavax has teamed up with Sanofi. Analysts are saying the partnership could boost Novavax's chances of winning more Covid vaccine market share. Sanofi is a "powerhouse partner" with "strong vaccine expertise and distribution channels," Jefferies analysts said in a note on Sunday. This partnership has also triggered a $175 million milestone payment to Novavax from Sanofi as part of their deal. As they say 'Only love can truly save the world.' But I think money could also help.

Virtual Therapy: A Modern Pandora's Box?

In other news the Peterson Health Technology Institute (PHTI) released a report on virtual mental health solutions. Apparently digital therapy can improve symptoms of depression and anxiety but it might also increase healthcare costs. The organization found that prescription digital therapeutics decreased net health spending for commercial payers as well as Medicare at anticipated reimbursement rates. I must confess this is a bit of a head scratcher. Is it a blessing or a curse? Much like the contents of Pandora’s box some of these solutions offer hope while others… well let's just say they require careful consideration. The PHTI report highlights the need for 'thoughtful financially sustainable and clinically appropriate growth of these solutions.' Hear hear! Let's strive for progress not just profit and remember that true strength lies in both body and mind.